6.57
price up icon0.92%   0.06
after-market Dopo l'orario di chiusura: 6.59 0.02 +0.30%
loading
Precedente Chiudi:
$6.51
Aprire:
$6.49
Volume 24 ore:
4.15M
Relative Volume:
0.95
Capitalizzazione di mercato:
$1.58B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-28.57
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
+2.98%
1M Prestazione:
+49.66%
6M Prestazione:
+21.44%
1 anno Prestazione:
+15.87%
Intervallo 1D:
Value
$6.38
$6.57
Intervallo di 1 settimana:
Value
$6.235
$6.645
Portata 52W:
Value
$3.21
$7.18

Ardelyx Inc Stock (ARDX) Company Profile

Name
Nome
Ardelyx Inc
Name
Telefono
510-745-7047
Name
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Dipendente
395
Name
Cinguettio
@ardelyx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
ARDX's Discussions on Twitter

Confronta ARDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARDX
Ardelyx Inc
6.57 1.54B 386.15M -56.39M -55.19M -0.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-18 Ripresa H.C. Wainwright Buy
2025-05-02 Downgrade Raymond James Strong Buy → Outperform
2025-03-07 Ripresa Ladenburg Thalmann Buy
2025-03-04 Iniziato BTIG Research Buy
2024-11-11 Downgrade H.C. Wainwright Buy → Neutral
2024-07-02 Downgrade Piper Sandler Overweight → Neutral
2024-04-05 Iniziato Leerink Partners Outperform
2023-12-18 Iniziato Raymond James Strong Buy
2023-09-07 Iniziato H.C. Wainwright Buy
2023-08-25 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-03-03 Aggiornamento Wedbush Neutral → Outperform
2022-11-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-05-06 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-12-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2021-10-14 Downgrade Ladenburg Thalmann Buy → Neutral
2021-07-21 Downgrade Jefferies Buy → Hold
2021-07-20 Downgrade Piper Sandler Overweight → Neutral
2021-07-20 Downgrade Wedbush Outperform → Neutral
2021-03-23 Iniziato Wedbush Outperform
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2020-10-20 Ripresa Citigroup Buy
2020-02-18 Ripresa Jefferies Buy
2020-02-12 Iniziato Citigroup Buy
2020-02-10 Iniziato Cowen Outperform
2019-04-08 Iniziato Piper Jaffray Overweight
2018-08-24 Iniziato Jefferies Buy
2018-03-19 Ripresa Leerink Partners Outperform
2017-11-29 Reiterato Citigroup Buy
2017-11-22 Reiterato Ladenburg Thalmann Buy
2017-10-17 Ripresa Leerink Partners Outperform
2016-03-31 Iniziato Ladenburg Thalmann Buy
2016-03-09 Iniziato Cantor Fitzgerald Buy
2016-03-03 Iniziato Citigroup Buy
Mostra tutto

Ardelyx Inc Borsa (ARDX) Ultime notizie

pulisher
Sep 03, 2025

Ardelyx’s Strategic Momentum in Global Markets: Evaluating Near-Term Catalysts - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Will Ardelyx Inc. price bounce be sustainableTrade Exit Summary & Risk Controlled Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Regression analysis insights on Ardelyx Inc. performanceMarket Movement Recap & Real-Time Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will breakout in Ardelyx Inc. lead to full recoveryBreakout Watch & Step-by-Step Swing Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leading vs lagging indicators on Ardelyx Inc. performanceWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has Ardelyx Inc. found a price floorInsider Buying & Real-Time Buy Signal Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How Ardelyx Inc. stock performs during market volatilityTrend Reversal & Weekly Setup with High ROI Potential - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about Ardelyx Inc.’s comebackMarket Activity Report & AI Driven Stock Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to interpret RSI for Ardelyx Inc. stockWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Strategies to average down on Ardelyx Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ardelyx Inc. stock outlook for YEARWeekly Profit Analysis & Technical Pattern Recognition Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Live market analysis of Ardelyx Inc.Weekly Stock Report & Fast Moving Trade Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What makes Ardelyx Inc. stock price move sharplyStop Loss & Intraday High Probability Setup Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Ardelyx Inc. Testing Reversal Zone on Weekly Chart getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 02, 2025
pulisher
Sep 02, 2025

Ardelyx assumed with Strong Buy from Outperform at Raymond James - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 15:57:44 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 15:56:26 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Ardelyx Inc. benefit from macro trendsStop Loss & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can swing trading help recover from Ardelyx Inc. lossesJuly 2025 Retail & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What does recent volatility data suggest for Ardelyx Inc.GDP Growth & Verified Trade Idea Suggestions - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Live Scanner Shows Breakout on Ardelyx Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Aug 31, 2025

Is Ardelyx Inc. showing signs of accumulationWeekly Profit Report & Verified Entry Point Detection - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Why Ardelyx Inc. stock attracts strong analyst attention getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 31, 2025
pulisher
Aug 31, 2025

Earnings visualization tools for Ardelyx Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to forecast Ardelyx Inc. trends using time seriesBond Market & Long-Term Growth Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What’s the recovery path for long term holders of Ardelyx Inc.Market Risk Report & Capital Efficiency Focused Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal - MSN

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Ardelyx Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Visual trend scoring systems applied to Ardelyx Inc.July 2025 Movers & Accurate Intraday Trading Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Ardelyx Inc. stock poised for growthWeekly Stock Report & Low Volatility Stock Recommendations - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Will Ardelyx Inc. outperform the marketCEO Change & Weekly Market Pulse Updates - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Quant Strategy Flags Ardelyx Inc. for Entry getLinesFromResByArray error: size == 0 - 클래시안

Aug 29, 2025
pulisher
Aug 29, 2025

Ardelyx Stock (ARDX) Opinions on Insider Sale and CMS Case - Quiver Quantitative

Aug 29, 2025
pulisher
Aug 29, 2025

Multi asset correlation models including Ardelyx Inc.July 2025 Summary & Technical Pattern Based Buy Signals - Newser

Aug 29, 2025

Ardelyx Inc Azioni (ARDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ardelyx Inc Azioni (ARDX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Williams Laura A
Chief Patient Officer
Aug 26 '25
Sale
6.12
80,000
489,680
366,322
Kelliher Mike
Chief Business Officer
Aug 21 '25
Sale
5.93
5,417
32,132
276,741
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):